glp-1 agonist clinical trials Another milestone in the evolution of GLP-1-based diabetes therapies Can one drug do it
Description
22 FinanB.ClemmensenC.MllerT
Kim, and D
GLP-1R Lowers blood glucose by binding to GLP-1, mainly by stimulating insulin secretion and inhibiting glucagon secretion (Zheng et al., 2024)
Muscle tissue acts as a glucose sink, aiding in blood sugar regulation, and provides the structural integrity necessary to prevent falls and fractures
Apart from this, the reduction in matrix metalloproteinase-1 (MMP-1) levels mediated by GLP-1RA attenuates the proliferative capacity of cancer cells
